Fintel reports that on October 14, 2025, Morgan Stanley maintained coverage of Elevance Health (NYSE:ELV) with a Equal-Weight recommendation.
Analyst Price Forecast Suggests 6.63% Upside
As of September 30, 2025, the average one-year price target for Elevance Health is $373.55/share. The forecasts range from a low of $299.97 to a high of $584.15. The average price target represents an increase of 6.63% from its latest reported closing price of $350.34 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Elevance Health is 175,825MM, a decrease of 7.10%. The projected annual non-GAAP EPS is 41.95.
What is the Fund Sentiment?
There are 2,681 funds or institutions reporting positions in Elevance Health. This is an decrease of 53 owner(s) or 1.94% in the last quarter. Average portfolio weight of all funds dedicated to ELV is 0.41%, an increase of 12.17%. Total shares owned by institutions increased in the last three months by 1.26% to 241,218K shares. 
The put/call ratio of ELV is 0.81, indicating a bullish outlook.
What are Other Shareholders Doing?
Price T Rowe Associates holds 8,085K shares representing 3.59% ownership of the company. In its prior filing, the firm reported owning 9,143K shares , representing a decrease of 13.08%. The firm decreased its portfolio allocation in ELV by 27.29% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 7,265K shares representing 3.23% ownership of the company. In its prior filing, the firm reported owning 7,059K shares , representing an increase of 2.84%. The firm decreased its portfolio allocation in ELV by 17.88% over the last quarter.
Capital International Investors holds 6,488K shares representing 2.88% ownership of the company. In its prior filing, the firm reported owning 5,556K shares , representing an increase of 14.37%. The firm decreased its portfolio allocation in ELV by 8.54% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 6,413K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 6,324K shares , representing an increase of 1.40%. The firm decreased its portfolio allocation in ELV by 19.43% over the last quarter.
Wellington Management Group Llp holds 6,318K shares representing 2.81% ownership of the company. In its prior filing, the firm reported owning 5,795K shares , representing an increase of 8.28%. The firm decreased its portfolio allocation in ELV by 8.01% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
